EFFECTOR THERAPEUTICS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch EFTR and buy or sell other stocks, ETFs, and their options commission-free!

About EFTR

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). 

CEO
Stephen T. Worland
CEOStephen T. Worland
Employees
15
Employees15
Headquarters
Solana Beach, California
HeadquartersSolana Beach, California
Founded
2012
Founded2012
Employees
15
Employees15

EFTR Key Statistics

Market cap
0.00
Market cap0.00
Price-Earnings ratio
-12.57
Price-Earnings ratio-12.57
Dividend yield
—
Dividend yield—
Average volume
2.96M
Average volume2.96M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
110.00
Volume110.00
52 Week high
$1.48
52 Week high$1.48
52 Week low
$0.3378
52 Week low$0.3378
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.